Drug Attitude Inventory

1983 ◽  
Author(s):  
Thomas P. Hogan ◽  
A. George Awad ◽  
Robin Eastwood
Keyword(s):  
Attitude Inventory ◽  
Drug Attitude Inventory ◽  
Drug Attitude

Drug Attitude Inventory-30--Tunisian Version

2015 ◽  
Author(s):  
Jaafar Nakhli ◽  
Badii Amamou ◽  
Salem Mlika ◽  
Saoussen Bouhlel ◽  
Marwan Trifi ◽  
...  
Keyword(s):  
Attitude Inventory ◽  
Drug Attitude Inventory ◽  
Drug Attitude

Drug attitude inventory, spanish-adapted version

2000 ◽  
Vol 10 ◽  
pp. 298-299 ◽  
Author(s):  
I. García Cabeza ◽  
J.A. Hormaechea Beldarrain ◽  
M. Sanz Amador ◽  
C. Arango López ◽  
M. González de Chávez
Keyword(s):  
Attitude Inventory ◽  
Drug Attitude Inventory ◽  
Drug Attitude

scholarly journals A modified Drug Attitude Inventory used in long-term patients in sheltered housing

2013 ◽  
Vol 23 (10) ◽  
pp. 1296-1299 ◽  
Author(s):  
Sigrid Stjernswärd ◽  
Karin Persson ◽  
René Nielsen ◽  
Eva Tuninger ◽  
Sten Levander
Keyword(s):  
Sheltered Housing ◽  
Attitude Inventory ◽  
Drug Attitude Inventory ◽  
Drug Attitude

Drug Attitude Inventory—10-Item Version

1983 ◽  
Author(s):  
T. P. Hogan ◽  
A. George Awad ◽  
M. R. Eastwood
Keyword(s):  
Attitude Inventory ◽  
Drug Attitude Inventory ◽  
Drug Attitude

scholarly journals Drug Attitude Inventory In Bipolar I Patients: Psychometric Properties

2018 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Behnam Shariati ◽  
Amir Shabani ◽  
Elmira Ariana-Kia ◽  
Masoud Ahmadzad-Asl ◽  
Kaveh Alavi ◽  
...  
Keyword(s):  
Psychometric Properties ◽  
Attitude Inventory ◽  
Drug Attitude Inventory ◽  
Drug Attitude

Therapeutic attitudes and clinical global impression: A 2-year follow-up study of 33 outpatients with a mental disorder in treatment with paliperidone palmitate

2016 ◽  
Vol 33 (S1) ◽  
pp. S616-S617
Author(s):  
M.D. Perez Lopez ◽  
M. Soto laguna ◽  
J. Prados Gomez ◽  
I. Zarranz Herrera Oria ◽  
R. Perez Asenjo ◽  
...  
Keyword(s):  
Mental Disorder ◽  
Clinical Global Impression ◽  
Paranoid Schizophrenia ◽  
Paliperidone Palmitate ◽  
Antipsychotic Therapy ◽  
Attitude Inventory ◽  
Axis I ◽  
Long Acting ◽  
Drug Attitude Inventory ◽  
Drug Attitude

IntroductionMaintaining antipsychotic therapy in mental disorder is important in preventing relapse, rehospitalization, and suicide. Lack of awareness of illness may be a leading cause for non-adherence. Long-acting depot can prevent non- adherence and thus potentially contribute to better patient outcomes.ObjectiveThe aim of this prospective, observational, non interventional 2-year-long study is to assess severity and post-intervention changes and attitudes toward medication of a group of patients treated paliperidone palmitate (PP).MethodsThirty-three outpatients stabilised with PP during the last 24 months. Inclusion criteria were: patients’ age (> 18 years), a diagnosis of schizophrenia, bipolar disorder, schizoaffective disorder stabilised during the last 12 months with PP, without a diagnostics from axis I or II (except for nicotine of caffeine) and able to sign the inform consent. Data collected: general sociodemographic and clinical data (age, sex, level of education, socioeconomic situation, family support, psychiatric diagnosis, years of evolution, use/abuse of substances, treatment, previous and later number of hospitalisations. Evaluations included disease severity (Clinical Global Impression-Severity (CGI-S) and Drug Attitude Inventory, (DAI)).ResultsThirty-threeoutpatients were followed during 24 months [mean dose 132,58 (44,4) mg], 75,8% were men, age 45,05 years old, 87,8% with a diagnoses of paranoid schizophrenia. Antipsychotic monotherapy increased over the time with PP. Significant improvements were observed on both Clinical Global Impression and Drug Attitude Inventory. The number of rehospitalizations and mean stays decreased from the beginning until the end of these 24 months.ConclusionsOur results suggest an improvement in the patient's clinical vision and attitude towards medication with long-acting depot.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Subjective response to neuroleptic medication: a validation study of the Italian version of the Drug Attitude Inventory (DAI)

2001 ◽  
Vol 10 (2) ◽  
pp. 107-114 ◽  
Author(s):  
Alessandro Rossi ◽  
Luca Arduini ◽  
Stefano De Cataldo ◽  
Paolo Stratta
Keyword(s):  
Validation Study ◽  
Sono State ◽  
Subjective Response ◽  
Italian Version ◽  
Neuroleptic Medication ◽  
I 18 ◽  
Attitude Inventory ◽  
Drug Attitude Inventory ◽  
Drug Attitude

RIASSUNTOScopo – Verificare se la versione italiana della Drug Attitude Inventory mantiene le proprietà psicometriche del questionario originate attraverso una validazione di costrutto. Setting – Lo studio è stato condotto su 90 pazienti con diagnosi di Disturbo Schizofrenico (n=72) e Disturbo Schizoaffettivo (n=18) ammessi al ricovero volontario per un episodio indice di riesacerbazione psicotica, d'età compresa tra i 18 ed i 50 anni, in trattamento con farmaci antipsicotici tipici e cognitivamente in grado di comprendere e rispondere alle domande del questionario. Disegno – Sono state impiegate analisi fattoriali esplorative con i metodi d'estrazione alfa fattoriale e della massima verosimiglianza; successivamente è stato utilizzato il metodo di Rotazione Varimax. Risultati – I metodi d'estrazione utilizzati trovavano 7 fattori che spiegavano il 62.5% della varianza. I primi 2 fattori possono essere identificati nel costrutto di “risposta soggettiva al trattamento” ed i fattori da 3 a 7 nel costrutto di “atteggiamento nei confronti della terapia”. Conclusioni – Benché lo studio sia preliminare, la traduzione italiana dello strumento sembra mantenere le proprietà psicometriche della versione originale e può essere utilizzata nella pratica clinica per una valida misurazione deH'atteggiamento del paziente nei confronti del trattamento con farmaci antipsicotici.

Sign in / Sign up

Export Citation Format

Share Document